Literature DB >> 3486707

Statement on Haemophilus influenzae type b polysaccharide vaccine.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3486707      PMCID： PMC1491261     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Hemophilus influenzae bacteremia in children with sickle cell disease.

Authors:  J Ward; A L Smith
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

2.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

3.  Hemophilus influenzae type b disease. An epidemiologic study with special reference to day-care centers.

Authors:  S R Redmond; M E Pichichero
Journal:  JAMA       Date:  1984-11-09       Impact factor: 56.272

4.  Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.

Authors:  S L Cochi; C V Broome; A W Hightower
Journal:  JAMA       Date:  1985-01-25       Impact factor: 56.272

5.  Age-related response to two Haemophilus influenzae type b vaccines.

Authors:  D J Pincus; D Morrison; C Andrews; E Lawrence; S H Sell; P F Wright
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

6.  Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.

Authors:  M L Lepow; G Peter; M P Glode; R S Daum; G Calnen; K M Knight; D Mayer; J S Kuo; N S Lui
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

7.  Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae: their occurrence and course in children with cancer.

Authors:  G R Siber
Journal:  Am J Dis Child       Date:  1980-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.